Casting a Wider NET: Pancreatic Exocrine Insufficiency Induced by Somatostatin Analogues among Patients with Neuroendocrine Tumours?

Casting a Wider NET: Pancreatic Exocrine Insufficiency Induced by Somatostatin Analogues among Patients with Neuroendocrine Tumours?

Somatostatin-analogues (SSAs) are a first-line treatment of unresectable neuroendocrine tumours (NETs). However, SSAs inhibit pancreatic secretions, which could lead to pancreatic exocrine insufficiency (PEI). PEI is known to be detrimental to patient quality of life and nutritional status. This stu...

Full description

Bibliographic Details
Main Authors: Lewis A. Hall, Sarah Powell-Brett, Oscar Thompson, Daniel Smith, Elizabeth Bradley, Stacey Smith, Suzanne Vickrage, Joanne Kemp-Blake, Keith J. Roberts, Tahir Shah
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Cancers
Subjects:
pancreatic exocrine insufficiency
neuroendocrine tumour
somatostatin-analogues
<sup>13</sup>C-MTG breath test
faecal-elastase-1
Online Access:https://www.mdpi.com/2072-6694/15/7/1933

Internet

https://www.mdpi.com/2072-6694/15/7/1933

Similar Items